Drug Innovation

For years, the left’s campaign to dictate the price of prescription drugs has focused on one medicine above all others — insulin. The hormone was discovered more than a century ago by Canadian doctor Frederick Banting and his medical student Charles Best. They famously sold their patent to the University of ...

Earlier this year, European authorities recommended approval of tofersen, a new drug that treats a rare genetic form of amyotrophic lateral sclerosis, or ALS. That decision came nearly a year after American regulators granted the drug accelerated approval. Patients with that rare form of ALS in England aren’t so lucky. The National Institute for ...

Last month at a White House event, President Joe Biden and Sen. Bernie Sanders, I-Vt., took a victory lap for supposedly having “beat Big Pharma” through drug-pricing provisions in the Inflation Reduction Act. Beaming with pride, they hailed new powers for Medicare to “negotiate” drug prices as a historic achievement. But their self-congratulation rests ...

Cost Plus Drug Company CEO Mark Cuban recently pointed out that self-insured businesses could save over $70,000 per employee annually by getting their workers to switch from AbbVie’s blockbuster anti-inflammatory treatment Humira to a lower-cost biosimilar called Yusimry. Humira has a list price of roughly $7,000 per month. Since it lost market exclusivity last year, nine nearly identical copycats have hit ...

Following an enormous cyberattack on a subsidiary of UnitedHealth Group, the Senate Finance Committee has called the company’s CEO, Andrew Witty, to testify on April 30th. The hackers stole millions of medical records, which reflects badly on the company’s ability to protect patients. But while members of Congress are grilling Witty about the ...

Speaking at a White House event with Sen. Bernie Sanders, I-Vt., very recently, President Biden crowed about his rapidly progressing scheme to impose price controls on prescription drugs. “Finally — finally we beat Big Pharma,” he said to Sanders. Unfortunately for Americans — and indeed, patients everywhere — the Democrats’ assault on the drug industry ...

By Sally Pipes & Wayne Winegarden  Question: What’s worse than government bureaucrats in Washington declaring the value of your medicine? Answer: Bureaucrats from Boston, London, Ottawa and Diemen establishing that value. Unfortunately, this is not a joke. It is the direction that the Institute for Clinical and Economic Review is ...

Like most pharmaceutical companies, Gilead Sciences Inc. devotes a huge amount of time and money to making sure its products are safe for patients. The U.S. Food and Drug Administration approved its drugs to fight HIV, and these medications have worked remarkably well. It then developed the next generation of ...

Any list of the world’s most inhumane healthcare bureaucracies has to include Britain’s National Institute for Health and Care Excellence at the top. For over two decades, the agency has employed ruthless cost-benefit analyses to effectively deny British patients access to the latest medicines. Now NICE is looking to export its expertise rationing ...